The Additional Dosage Routes Module (ADRM) in GastroPlus® extends the program beyond the traditional oral and intravenous drug administration routes. It currently includes five dosage routes: ocular, nasal-pulmonary, transdermal, oral cavity, and injectables (intramuscular, intraarticular, and subcutaneous). This bundle includes transdermal, ocular, nasal-pulmonary, and oral cavity administrations. Training sessions will be conducted through the Simulations Plus Training Portal as On Demand content. Participants will attend virtually. You must have access to the associated modules. Click on register for more information.
Transdermal Administration
This workshop will explore transdermal compound administration by representing the skin as a collection of compartments. By using this module, you will learn how to simulate a variety of transdermal dosage forms, including one or more of the following: solutions, lotions, suspensions, gels, creams, and patches.
Ocular Administration
This workshop will explore ocular compound administration by representing the eye as a collection of compartments. By using this module, you will learn how to simulate a variety of ocular dosages, including one or more of the following: topical solution or suspension, intravitreal injection and/or intravitreal or subcutaneous implants
Nasal-Pulmonary Administration
This workshop will explore pulmonary compound administration by representing the lung and nose as a collection of compartments. By using this module, you will learn how to simulate a variety of pulmonary dosage routes, including one or more of the following: inhaled bolus or infusion as powders or solutions, intratracheal administrations, and nasal sprays.
Oral Cavity Administration
This workshop will explore oral cavity compound administration by representing the mouth as a collection of compartments. By using this module you will learn how to simulate a variety of oral cavity dosage routes, including one or more of the following: sublingual solutions and tablets, lingual sprays, sublingual tablets, and/or controlled release buccal patches.
